FDC Limited (BOM:531599)
India · Delayed Price · Currency is INR 384.60
-0.10 (-0.03%)
At close: Jun 16, 2026
FDC Limited Market Cap
FDC Limited has a market cap or net worth of 62.62 billion as of June 16, 2026. Its market cap has decreased by -16.30% in one year.
Market Cap
62.62B
Enterprise Value
57.54B
Revenue
21.71B
Ranking
n/a
PE Ratio
22.24
Stock Price
384.60
Market Cap Chart
Since May 30, 2002, FDC Limited's market cap has increased from 2.73B to 62.62B, an increase of 2,195.73%. That is a compound annual growth rate of 13.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 62.62B | -9.14% |
| Dec 31, 2025 | 68.92B | -15.14% |
| Dec 31, 2024 | 81.22B | 25.96% |
| Dec 29, 2023 | 64.48B | 43.15% |
| Dec 30, 2022 | 45.04B | -12.27% |
| Dec 31, 2021 | 51.34B | -8.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jubilant Pharmova | 154.48B |
| Viyash Scientific | 109.09B |
| CORONA Remedies | 105.70B |
| Procter & Gamble Health | 104.14B |
| Sanofi India | 71.85B |
| Bliss GVS Pharma | 46.35B |
| Gufic Biosciences | 37.23B |
| Novartis India | 32.19B |